mbiomics

Microbiotica

This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.

MRM Health

This biopharmaceutical company develops microbiome-based live biotherapeutic products for patients with chronic inflammatory diseases and immune-oncology conditions.

Kanvas Biosciences

This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.

EnteroBiotix

This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.

Enterbiotix

This company develops orally administered microbiome therapeutics to treat patients with gastrointestinal conditions including irritable bowel syndrome and liver cirrhosis.

Metabogen

This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.

BEO Therapeutics

This company develops oral microbiome therapies to treat patients with gouty arthritis and chronic kidney disease by reducing metabolic waste products.